Unknown

Dataset Information

0

Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells.


ABSTRACT: Although clinical responses with CD19-targeting chimeric antigen receptor (CAR) T-cell treatment have been observed in patients with certain hematologic malignancies, high rates of disease relapse highlight the necessity to understand and improve mechanisms of CAR T-cell failure. Because T-cell dysfunction is thought to contribute to CAR T-cell treatment failure, understanding what mechanisms drive T cells into this dysfunctional state may aid optimal design of efficacious CAR T cells. Dysfunctional CAR T cells have been characterized as having upregulated inhibitory receptors and decreased cytolytic capabilities. Previous studies have identified a role for sustained CAR CD3? signaling in CAR T-cell dysfunction. Here, we demonstrate a mechanism that drives dysfunction in CAR T cells through excessive costimulation. Fully activated CD19-targeted CAR T cells were rendered dysfunctional upon stimulation with both endogenous CD28 stimulation and CAR-mediated CD28 costimulation. Costimulation-driven dysfunction of CAR T cells was demonstrated in a syngeneic immunocompetent mouse model, in which CAR T cells were activated with signals 1 (CD3?), 2 (CD28), and 3 (IL12). Thus, we show that CAR T-cell dysfunction can be driven through excessive CD28 and 4-1BB costimulation.See related article by Drakes et al., p. 743.

SUBMITTER: Wijewarnasuriya D 

PROVIDER: S-EPMC7269815 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells.

Wijewarnasuriya Dinali D   Bebernitz Christina C   Lopez Andrea V AV   Rafiq Sarwish S   Brentjens Renier J RJ  

Cancer immunology research 20200325 6


Although clinical responses with CD19-targeting chimeric antigen receptor (CAR) T-cell treatment have been observed in patients with certain hematologic malignancies, high rates of disease relapse highlight the necessity to understand and improve mechanisms of CAR T-cell failure. Because T-cell dysfunction is thought to contribute to CAR T-cell treatment failure, understanding what mechanisms drive T cells into this dysfunctional state may aid optimal design of efficacious CAR T cells. Dysfuncti  ...[more]

Similar Datasets

| S-EPMC5674950 | biostudies-literature
| S-EPMC3668849 | biostudies-literature
| S-EPMC3017450 | biostudies-literature
| S-EPMC3178185 | biostudies-literature
| S-EPMC5626814 | biostudies-literature
| S-EPMC6167529 | biostudies-literature
| S-EPMC4084557 | biostudies-literature
| S-EPMC5342484 | biostudies-literature
| S-EPMC1783812 | biostudies-literature